phenytoin has been researched along with Colitis, Granulomatous in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with Crohn's disease and generalized seizures who lacked the distal small bowel and ascending colon required 600 mg of intravenous phenytoin daily (11 mg/kg/24 h) to maintain her plasma phenytoin levels in the 12-24 micrograms/ml range." | 1.27 | Enhanced gastrointestinal excretion of phenytoin in a patient with Crohn's disease. ( Gardner, M; Irace, P; Kutt, H; Lesser, RP; Pippenger, CE; Terrentine, S; Winkelman, EL, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lesser, RP | 1 |
| Irace, P | 1 |
| Kutt, H | 1 |
| Pippenger, CE | 1 |
| Winkelman, EL | 1 |
| Terrentine, S | 1 |
| Gardner, M | 1 |
1 other study available for phenytoin and Colitis, Granulomatous
| Article | Year |
|---|---|
Enhanced gastrointestinal excretion of phenytoin in a patient with Crohn's disease.
Topics: Adult; Crohn Disease; Female; Humans; Injections, Intravenous; Intestinal Absorption; Phenytoin | 1984 |